RP-LC Determination and Pharmacokinetic Study of Ferulic Acid and Isoferulic Acid in Rat Plasma After Taking Traditional Chinese Medicinal-Preparation: Guanxinning Lyophilizer

A sensitive, simple, and accurate method for determination and pharmacokinetic study of ferulic acid and isoferulic acid in rat plasma was developed using a reversed-phase column liquid chromatographic (RP-LC) method with UV detection. Sample preparations were carried out by protein precipitation with the addition of methanol, followed by evaporation to dryness. The resultant residue was then reconstituted in mobile phase and injected into a Kromasil C₁₈ column (250 × 4.6 mm i.d. with 5 μm particle size). The mobile phase was methanol-1% formic acid (33:67, v/v). The calibration plots were linear over the range 5.780–5780 ng·mL⁻¹ for ferulic acid and 1.740–348.0 ng·mL⁻¹ for isoferulic acid. Mean recoveries were 85.1% and 91.1%, respectively. The relative standard deviations (RSDs) of within-day and between-day precision were not above 15% for both of the analytes. The limits of quantification were 5.780 ng·mL⁻¹ for ferulic acid and 1.740 ng·mL⁻¹ for isoferulic acid. This RP-LC method was used successfully in pharmacokinetic studies of ferulic acid and isoferulic acid in rat plasma after intravenous injection of Guanxinning Lyophilizer.

     

RP-HPLC Determination and Pharmacokinetic Comparison of Cinnamic Acid in Rat Plasma After Administration of Di-Gu-Pi Decoction and Pure Cinnamic Acid

IntroductionTraditionally,Di-Gu-Pi has been used as a naturaltherapeutic agent for the treatment of diabetes,hemor-rhagic inframmation,hypertension,ulcers,and feverunder the guidance of the theory of Traditional ChineseMedicinal(TCM)science[1].This fact h…     

Rapid and Sensitive RP-LC Method for the Quantification and Pharmacokinetic Study of p-Hydroxyphenethyl Anisate in Rat Plasma

A rapid, sensitive and specific reversed-phase liquid chromatographic method was developed and validated for the quantification of p-hydroxyphenethyl anisate (HPA), which is one of the main constituents of Notopterygium Radix (underground parts of Notopterygium incisum and N. forbesii), in rat plasma, and study its pharmacokinetics after the intravenous administration of 40 mg kg^?1 HPA to rats. The method involves a plasma clear-up step using liquid–liquid extraction by ethyl acetate, followed by RP-LC separation and detection. Separation of HPA was performed on an analytical Diamonsil ODS C₁₈ column equipped with a Dikma ODS C₁₈ EasyGuard column using a mobile phase consisting of MeOH–H₂O (75:25, v/v) at a flow-rate of 1.0 mL min^?1. The UV detection was performed at a wavelength of 256 nm. The linear calibration curves were obtained in the concentration range of 0.05–5.0 μg mL^?1 (r = 0.9992, n = 5) in rat plasma with the lower limit of detection of 0.01 μg mL^?1 and the lower limit of quantification of 0.04 μg mL^?1, and the extraction recovery of HPA was calculated to be the range of 82.01–86.66%. The intra- and inter-day precisions in terms of % relative standard deviation were lower than 2.33 and 3.99% in rat plasma, respectively, with accuracies ranging from 91.22 to 110.5%. The developed method was suitable for the determination and pharmacokinetic study of HPA in rat plasma.     

Determination of Tetrandrine in Rat Whole Blood by RP-LC and Its Application to Pharmacokinetic Studies

A simple, specific and sensitive RP-LC method was developed and validated for the determination of tetrandrine in rat whole blood for the first time. Chromatographic separation was performed on a Welchrom^TM C18 analytical column at a flow rate of 1.0 mL min^?1, using a mixture of methanol-water containing 0.6% triethylamine and 0.16% phosphoric acid as mobile phase. The wavelength for UV detection was set at 225 nm. Sample preparation involved a liquid-liquid extraction using n-hexane. The calibration curve was linear with r ² > 0.99 over a concentration range of 0.03?C6.4 ??g mL^?1 in rat whole blood with a lower limit of quantification of 0.03 ??g mL^?1. The intra- and inter-day precisions were 1.33?C4.55 and 3.33?C4.65%, respectively, and the intra- and inter-day accuracy ranged from ?5.24 to 0.90% and ?1.05 to 0.63%, respectively. No endogenous compounds were found to interfere with the analytes. Tetrandrine was stable for 8 h at room temperature, 24 h at 4 °C in rat whole blood, and for 30 days at ?20 °C after being prepared. For the first time, the present method was successfully applied to the pharmacokinetic studies of tetrandrine in rats after intravenous administration of three different doses. The results indicated that the pharmacokinetics of tetrandrine on rats was a first-order process.     

Determination of Tectorigenin in Rat Plasma: Application to a Pharmacokinetic Study After Oral Administration of Tectorigenin or Its Prodrug Tectoridin

A simple, sensitive, and validated liquid chromatographic method has been developed for the determination of tectorigenin in rat plasma and application to a pharmacokinetic study after oral administration of tectorigenin or its prodrug tectoridin. The analysis was performed on a Kromasil C₁₈ analytical column using gradient elution with acetonitrile 0.1% phosphonic acid water at 0.8 mL min⁻¹. The detection wavelength for UV detection was set at 264 nm. The established method was fully validated with parameters as follows: the intra- and inter-day assay precisions (CV) of three analytes were in the range of 4.2–13.3% and accuracies were between 98.0 and 107.5%; the calibration curve was linear with r ² > 0.99 over a concentration range of 0.02–2 μg mL⁻¹; the lower limit of quantification was 0.02 μg mL⁻¹; tectorigenin showed stable in rat plasma after 12 h incubation at room temperature, 15 days storage at −80 °C and three freeze/thaw cycles, as well as in reconstitute buffer for 24 h at 25 °C; and the mean recoveries of tectorigenin were 92.3 ± 3.2, 95.5 ± 2.9 and 94.5 ± 3.0% with quality control levels of 0.02, 0.2 and 2 μg mL⁻¹, respectively. In conclusion, this method is simple, economic, and sensitive enough for in vivo pharmacokinetic studies of tectorigenin.

     

Determination of Tectorigenin in Rat Plasma: Application to a Pharmacokinetic Study After Oral Administration of Tectorigenin or Its Prodrug Tectoridin

A simple, sensitive, and validated liquid chromatographic method has been developed for the determination of tectorigenin in rat plasma and application to a pharmacokinetic study after oral administration of tectorigenin or its prodrug tectoridin. The analysis was performed on a Kromasil C₁₈ analytical column using gradient elution with acetonitrile 0.1% phosphonic acid water at 0.8 mL min^?1. The detection wavelength for UV detection was set at 264 nm. The established method was fully validated with parameters as follows: the intra- and inter-day assay precisions (CV) of three analytes were in the range of 4.2–13.3% and accuracies were between 98.0 and 107.5%; the calibration curve was linear with r ² > 0.99 over a concentration range of 0.02–2 μg mL^?1; the lower limit of quantification was 0.02 μg mL^?1; tectorigenin showed stable in rat plasma after 12 h incubation at room temperature, 15 days storage at ?80 °C and three freeze/thaw cycles, as well as in reconstitute buffer for 24 h at 25 °C; and the mean recoveries of tectorigenin were 92.3 ± 3.2, 95.5 ± 2.9 and 94.5 ± 3.0% with quality control levels of 0.02, 0.2 and 2 μg mL^?1, respectively. In conclusion, this method is simple, economic, and sensitive enough for in vivo pharmacokinetic studies of tectorigenin.     

Simultaneous Determination of Three Flavonoids in Rat Plasma by RP-LC After Oral Administration of the Total Flavonoids of Scutellaria barbata

A liquid chromatographic method for the simultaneous determination of three flavonoids, scutellarin (SCU), isoscutellarein-8-O-glucuronide (ISO) and luteolin (LUT) in rat plasma was developed and validated. Following a single-step liquid–liquid extraction with ethyl acetate, the analytes and internal standard (IS) (rutin) were successfully separated on a Diamonsil C₁₈ column using a mobile phase composed of acetonitrile (A)–0.2% phosphoric acid aqueous solution (B) (0–5 min, 20% A–29% A; 5–25 min, 29% A, v/v) at a flow rate of 1.0 mL min^?1. The linear range was 0.044–2.20 μg mL^?1 for SCU, 0.042–2.08 μg mL^?1 for ISO, and 0.056–2.80 μg mL^?1 for LUT, with the correlation coefficients of 0.9995, 0.9989 and 0.9963, respectively. The limit of quantification of SCU, ISO and LUT were 44, 41.6 and 56 ng mL^?1, respectively. The accuracy of assay was between 88.4 and 103.0%. The inter-day and intra-day precisions (RSD) were less than 10.5%. The developed method was simple, rapid and applied successfully to study the pharmacokinetics of SCU, ISO and LUT after oral administration of the total flavonoids of Scutellaria barbata.     

High-Performance Liquid Chromatographic Method for Determination and Pharmacokinetic Study of Chlorogenic Acid in the Plasma of Rats After Administration of the Chinese Medicinal Preparation Luying Decoction

A simple and sensitive high-performance liquid chromatographic method has been developed for determination of chlorogenic acid in rat plasma. Chlorogenic acid was extracted from plasma samples with methanol. HPLC analysis of the extracts was performed on a C₁₈ column (250 mm × 4.6 mm i.d., 5 µm particles). The mobile phase was acetonitrile −1% formic acid (9:91, v/v). The calibration plot was linear over the range 0.0420–2.10 µg mL⁻¹ and the lower limit of quantification was 0.0420 µg mL⁻¹. The method was reproducible and reliable with intra-day precision better than 8.2%, inter-day precision better than 9.1%, accuracy within ±8.3%, and mean extraction recovery above 84.4%. The validated method was successfully applied to pharmacokinetic studies of chlorogenic acid in rat plasma after administration of Luying decoction.     

Determination of Baicalin in Rat Hippocampus by RP-LC After Intravenous Administration of Flavonoids from Scutellariae Radix

A rapid and sensitive method to assay baicalin in rat hippocampus was applied using a simple liquid-liquid extraction technique followed by high-performance liquid chromatography. Baicalin and the internal standard, 4-nitro-benzoic acid, were extracted twice from the homogenized solution with acetonitrile and after centrifugation the combined extracts were evaporated. To the remaining residue 0.1 mL of methanol were added to obtain the sample solution. A 10 μL volume of sample solution was injected onto HPLC for analysis carried out on a Zorbax SB-C₁₈ column using a mobile phase of methanol–water-H₃PO₄ (45:55:0.2, v/v/v, pH 3.0) at 277 nm with a UV detector. The calibration curve for baicalin was linear over the concentration range of 0.05–1.6 μg mg^?1 in hippocampus. Recoveries were reasonable for routine analyses (>88%) and the LOD and LOQ ranged from 0.006 to 0.009 μg mg^?1 and 0.015 to 0.035 μg mg^?1, respectively. The coefficient of variation of the assay precision was less than 5.9%, and the accuracy exceeded 98%. The method was applied to determine the time course of baicalin in rat hippocampus, following the intravenously administration of flavonoids from Scutellariae Radix extract at 90 mg kg^?1 of baicalin to a male Wistar rat. This method provides a very simple, sensitive, and accurate way to determine baicalin concentrations in rat hippocampus.     

高效液相色谱法测定血浆中阿魏酸的含量

建立了一种快速、稳定的高效液相色谱-二极管阵列检测法(HPLC-DAD),用于测定健康人口服阿魏酸钠片后,血浆中阿魏酸的含量。该方法采用DIONEX C18色谱柱(250×4.6mm i.d.,5μm),流动相为甲醇-磷酸缓冲溶液(0.1%),梯度洗脱,检测波长为322nm。结果显示:人体血浆中的阿魏酸提取回收率大于60%。阿魏酸的含量在0.025～8.0μg/mL范围内线性良好,相关系数r=0.9994。方法检出限(S/N=3)为0.025μg/mL。日内相对标准偏差(RSD)小于1.02%,日间RSD小于2.1%。该法可用于人体血浆中阿魏酸的药代动力学研究。     

LC–MS Determination and Pharmacokinetic Study of a Novel Sulfonylurea: Potential Hypoglycemic Agent in Rat Plasma

To support preclinical pharmacokinetic investigation of 1-[4-[2-(4-bromobenzene-sulfonaminoethyl)phenylsufonyl]-3-(trans-4-methylcyclohexyl)urea (G004), a rapid, sensitive and specific high-performance liquid chromatography–electrospray ionization mass spectrometry (LC–ESI-MS) method was developed and validated. Glibenclamide was employed as internal standard. After liquid–liquid extraction the analyte was analyzed on a Kromasil C₁₈ column (150 × 2.0 mm i.d.) with a mobile phase consisted of acetonitrile–water (0.05% acetic acid), 30:70 (v/v). The flow rate was 0.2 mL min⁻¹. Detection was performed on a quadrupole mass spectrometer using an electrospray ionization interface and the selected-ion monitoring (SIM) mode. The retention time was about 3.5 and 4.2 min for Glibenclamide and G004, respectively. The assay was linear over the concentration range of 2.0–500.0 ng mL⁻¹. Extraction Recovery of G004 in rat plasma was more than 87%. The intra- and inter-assay precision was lower than 11.5% (CV). This validated method was successfully applied to the pharmacokinetics of G004 in rats.     

Determination of Gallic Acid in Rat Plasma by LC-MS-MS

Liquid chromatography–electrospray ionization tandem mass spectrometry has been used for rapid, selective, and sensitive quantitative analysis of gallic acid in rat plasma. Sample pretreatment involved a one-step extraction using ethyl acetate with protocatechic acid as internal standard. Separation was on a C₁₈ column using an isocratic mobile phase, consisting of methanol-0.1% aqueous formic acid (40:60, v/v) at 0.2 mL min⁻¹. The stability of gallic acid was evaluated in acidified and non-acidified plasma. The method was validated then successfully applied to a pharmacokinetic study in rats after oral administration of rhubarb extract.

     

Determination of Gallic Acid in Rat Plasma by LC-MS-MS

Liquid chromatography–electrospray ionization tandem mass spectrometry has been used for rapid, selective, and sensitive quantitative analysis of gallic acid in rat plasma. Sample pretreatment involved a one-step extraction using ethyl acetate with protocatechic acid as internal standard. Separation was on a C₁₈ column using an isocratic mobile phase, consisting of methanol-0.1% aqueous formic acid (40:60, v/v) at 0.2 mL min^?1. The stability of gallic acid was evaluated in acidified and non-acidified plasma. The method was validated then successfully applied to a pharmacokinetic study in rats after oral administration of rhubarb extract.     

Determination of Chlorzoxazone in Rat Plasma by LC-ESI-MS/MS and Its Application to a Pharmacokinetic Study

A sensitive LC-ESI-MS/MS method for determination of chlorzoxazone in rat plasma has been developed. Chromatographic separation was achieved on a Zorbax SB-C₁₈ column, with 45:55 (v/v) acetonitrile–water as the mobile phase. A LC-ESI-MS/MS was performed in a multiple reactions monitoring (MRM) mode using target ions m/z 167.5→131.6 for chlorzoxazone and m/z 230.7→185.6 for phenobarbital (internal standard). The calibration plots were linear over the range of 10.0–2,000 ng/mL. Intra-day and inter-day precisions were better than 5.1% and 6.8%, respectively. The validated method was successfully used to analyze the drug in samples of rat plasma for pharmacokinetic study.     

Hollow-Fiber-Based LPME as a Reliable Sampling Method for Gas-Chromatographic Determination of Pharmacokinetic Parameters of Valproic Acid in Rat Plasma

A sensitive and simple method based on two-phase liquid-phase microextraction in porous hollow fiber followed by gas chromatography-flame ionization detection was developed for quantification and pharmacokinetic study of valproic acid (VPA, an antiepileptic drug) in rat plasma after oral administration of pure sodium valproate (25 mg kg^?1). Some parameters such as type of organic solvent, pH of sample solution, stirring speed, salt addition, extraction time, and volume of sample that affected extraction efficiency of VPA were optimized. Under optimized microextraction conditions, VPA was extracted with 10 μL 1-octanol from 0.5 mL rat plasma previously diluted with 4.5 mL acidified and salinated water (pH 2) using 1-octanoic acid as internal standard. The limit of detection was 17 ng mL^?1 with linear response over the concentration range of 50–10,000 ng mL^?1 with correlation coefficient higher than 0.998. The developed method was successfully applied to determination of pharmacokinetic parameters such as t _max (peak time in concentration–time profile), C _max (peak concentration in concentration–time profile), t _1/2 (elimination half-life), AUC_0–t (area under the curve for concentration versus time), clearance, and apparent distribution volume in rats following oral administration of VPA.     

Hollow-Fiber-Based LPME as a Reliable Sampling Method for Gas-Chromatographic Determination of Pharmacokinetic Parameters of Valproic Acid in Rat Plasma

A sensitive and simple method based on two-phase liquid-phase microextraction in porous hollow fiber followed by gas chromatography-flame ionization detection was developed for quantification and pharmacokinetic study of valproic acid (VPA, an antiepileptic drug) in rat plasma after oral administration of pure sodium valproate (25 mg kg⁻¹). Some parameters such as type of organic solvent, pH of sample solution, stirring speed, salt addition, extraction time, and volume of sample that affected extraction efficiency of VPA were optimized. Under optimized microextraction conditions, VPA was extracted with 10 μL 1-octanol from 0.5 mL rat plasma previously diluted with 4.5 mL acidified and salinated water (pH 2) using 1-octanoic acid as internal standard. The limit of detection was 17 ng mL⁻¹ with linear response over the concentration range of 50–10,000 ng mL⁻¹ with correlation coefficient higher than 0.998. The developed method was successfully applied to determination of pharmacokinetic parameters such as t _max (peak time in concentration–time profile), C _max (peak concentration in concentration–time profile), t _1/2 (elimination half-life), AUC_0–t (area under the curve for concentration versus time), clearance, and apparent distribution volume in rats following oral administration of VPA.

     

HPLC Determination and Pharmacokinetic Study of Valdecoxib in Human Plasma

A sensitive, simple, and accurate high-performance liquid chromatographic method has been developed for determination of valdecoxib and the internal standard rofecoxib in human plasma. Protein was precipitated from plasma samples by addition of perchloric acid (HClO₄); the drug was then extracted with diethyl ether. Separation was performed on a Cosmosil C₁₈ column (150 mm × 4.6 mm i.d., 5 m particles) with ammonium acetate buffer-acetonitrile, 60:40 (v/v), containing 0.1% TEA, pH 6.5, as mobile phase. Detection and quantification were performed by UV-visible detection at 239 nm. Detection and quantification limits were 3 and 5 ng mL^–1, respectively. The linear concentration range for valdecoxib was 5–400 ng mL^–1. The validated RP HPLC method was used for determination of the pharmacokinetic data for the drug in humans.     

LC Determination and Pharmacokinetic Study of Sinomenine in Dog Plasma

A simple HPLC method has been developed for determination of sinomenine in dog plasma and has been used to evaluate the pharmacokinetics of sinomenine tablets in dogs. Chromatographic separation was performed on a reversed-phase column with 0.78% (w/v) NaH₂PO₄-acetonitrile, 88:12 (v/v), as mobile phase, delivered at a flow rate of 1.5 mL min^?1. Detection was performed at 265 nm. The limit of quantification was 5.0 ng mL^?1. The calibration range was from 5.0 to 1000 ng mL^?1. The developed method was applied to pharmacokinetic studies of sinomenine sustained-release tablets (test preparation) and sinomenine conventional tablets (reference preparation) in six dogs. Pharmacokinetic data t _max, C _max, AUC _0-t , AUC _0-∞, and t _1/2 for both preparations were determined from plasma concentration-time profiles. The method was sufficiently sensitive, simple, and repeatable for use in pharmacokinetic studies.     

LC-MS-MS Determination and Pharmacokinetic Study of Clozapine in Human Plasma

A sensitive and selective liquid chromatographic method coupled with tandem mass spectrometry was established and validated for the determination and pharmacokinetic study of clozapine in human plasma. Ethyl acetate extraction was used for plasma sample preparation with mirtazapine as internal standard. Chromatographic separation was achieved on a Hanbon Kromasil C₁₈ (250 mm × 4.6 mm, 5 μm) column by isocratic elution with a mixture of 70 volumes of methanol and 30 volumes of water containing 0.2% ammonium acetate and 0.1% formic acid as mobile phase delivered at 1.0 mL min^?1. The MS-MS detection was carried out on a tandem mass spectrometer using positive electrospray ionization and multiple reaction monitoring with argon for collision-induced dissociation. The ion transitions were monitored as follows: m/z 327 to m/z 270 for clozapine and m/z 266 to m/z 195 for the internal standard (mirtazapine), respectively. Calibration curves were generated over the concentration range from 0.10 to 200 ng mL^?1 with the lower limit of quantification of 0.10 ng mL^?1, and two segments of linear calibration curves were established by regressing in the way of least-square in the range from 0.10 to 5.0 and 5.0 to 200 ng mL^?1, respectively. The intra- and inter-day precision and accuracy were determined at three different concentration levels, 0.20, 10.0 and 100 ng mL^?1, and were all better than 15% (n = 5). This specific and sensitive liquid chromatography coupled with tandem mass spectrometry has been successfully applied to a pharmacokinetic study of clozapine after a single oral dose of 25 mg in healthy Chinese volunteers.     

LC Determination and Pharmacokinetic Study of Gemfibrozil in Human Plasma

A simple and sensitive LC method for the quantitative determination of gemfibrozil in human plasma samples is described. Mometasone furoate was used as the internal standard. Plasma samples were pretreated by protein precipitation using methanol. Separation was performed at 40 °C on a YMC^® ODS-A reverse phase column (5 μm particle size, 150 mm × 4.6 mm i.d.) using 0.2% (v/v) triethylamine in water (adjusting to pH 4.0 with phosphoric acid) and acetonitrile (45:55, v/v) as mobile phase which was delivered at 1.5 mL min^?1. Ultraviolet detection was performed at 230 nm. The linear concentration range for gemfibrozil was 0.25–50 μg mL^?1. The detection limit of this method was 0.1 μg mL^?1. Intra- and inter-assay RSD ranged from 0.63 to 2.04% and 1.37 to 4.27%, respectively. The method was sensitive, simple and repeatable enough to be used in pharmacokinetic studies.